Skip to content

Molecular docking and network pharmacology analysis of the interactions of curcumin and curcumin-like molecules with GSK3-β.

Oct 2026 · Archives of Physiology and Biochemistry · pp. 1-23 · 0 citations · 49 references
Medicine

TL;DR

Overall, acitretin emerged as a computationally prioritised candidate for GSK3-β inhibition studies, but these findings remain computational predictions and require confirmation through experimental GSK3-β inhibition studies.

Abstract

Background: GSK3-β is a serine/threonine kinase involved in metabolic, inflammatory, oncogenic, and neurological signalling pathways. Methods: This study investigated curcumin and ten structurally similar compounds using an integrated in silico approach combining structural similarity screening, molecular docking, MD simulations, DFT calculations, ADMET/toxicity prediction, and network pharmacology. Results: Molecular docking identified phenothrin (-8.3 kcal/mol), acitretin (-8.0 kcal/mol), and curcumin (-7.5 kcal/mol) as the highest-ranking compounds, which were subsequently subjected to three independent 100-ns MD simulations. MD analyses indicated stable protein-ligand complexes, with acitretin showing a persistent and diverse interaction profile within the GSK3-β binding region. Comparative DFT analysis indicated distinct electronic characteristics among the three compounds, while ADMET profiling highlighted differences in their predicted pharmacokinetic and toxicological properties. Network pharmacology predictions associated acitretin-related targets with PPAR, PI3K-Akt, and other signalling pathways. Conclusion: Overall, acitretin emerged as a computationally prioritised candidate. However, these findings remain computational predictions and require confirmation through experimental GSK3-β inhibition studies.

View source

Similar papers

Sep 2026

Integration of network pharmacology, structure-based pharmacophore modeling, DFT, molecular docking, and molecular dynamics simulations to identify multi-target small molecule inhibitors against Alzheimer's disease.

The findings of this study suggest that Hit1 could be a promising multi-target molecule capable of modulating cholinergic transmission, neuronal survival pathways, and oxidative stress in AD.

D. O. Onwu, R. Oria, Y. A. Adekunle et al. · 0 citations
Sep 2026

Exploring Anti-Breast Cancer Potential and Mechanism of Novel Xanthohumol-Metformin Conjugate by Integrating Network Pharmacology, Molecular Docking and Simulation Approaches

An integrative in-silico pipeline supports the XN-MT conjugate as a potential candidate for further in-vitro studies and preclinical development in breast cancer therapy targeting CDK4.

V. Harish, Sharfuddin Mohd, Goparaju Kavya et al. · 0 citations
Open access Sep 2026

Integrated computational discovery of AMPK-activating flavonoids reveals curcumin, resveratrol, and tangeritin as promising neuroprotective candidates

Flavonoid activators of AMP-activated protein kinase (AMPK) are emerging as promising modulators of neurodegenerative disease–relevant pathways, yet a systematic, multi-level in silico comparison of candidate molecules is lacking. This study presents the first integrated computational pipeline that combines pharmacokin...

Bindiya Upadhyay, M. Jain · 0 citations
Oct 2026

Dual‐Target Molecular Docking and ADMET Analysis of Chalcone Derivatives against Neurorelevant Macromolecules in Alzheimer's Disease and Anxiety Disorders

The combined evaluation of dual‐target binding and pharmacokinetic profiling highlights the potential of n‐alkoxy chalcone derivatives as multifunctional neuroactive candidates and provides a rational basis for further experimental validation.

Mohammed H. Alheety, M. A. Guma, Mustafa A. Alheety et al. · 0 citations
Open access Nov 2026

Systems Pharmacology and Molecular Docking-Based Investigation of the Molecular Mechanism of Astilbin in the Treatment of Alzheimer's Disease.

This study combined systems pharmacology and computational biology to systematically investigate the multi-target mechanisms and network features of Astilbin, a natural flavonoid glycoside, in Alzheimer's disease (AD) intervention. We collected potential targets of astilbin and AD-associated genes from PharmGKB, GeneCa...

Si-Qi Huang, Quan-Zhou Lv, Liang-Chong Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.